Bristol Myers Squibb Co (BMY) stock
BMYNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as CELG.RI
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 14/3030% below fair value
$61.35−1.58 (-2.51%)
Close on Nov 17, 2026Market cap $125.41BP/E 13.6Yield 4.06%
Bristol Myers Squibb gross margin
Gross margin is gross profit as a percentage of revenue.
Bristol Myers Squibb's gross margin for the twelve months ending Sep 30, 2026 was 69.2%. For fiscal 2025 it was 71.1%, against 71.1% the year before. The highest annual figure on record is 78.6% in fiscal 2021.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 71.1% | +0.0 |
| FY2024 | Dec 31, 2024 | 71.1% | −5.2 |
| FY2023 | Dec 31, 2023 | 76.2% | −1.8 |
| FY2022 | Dec 31, 2022 | 78.0% | −0.5 |
| FY2021 | Dec 31, 2021 | 78.6% | +6.3 |
| FY2020 | Dec 31, 2020 | 72.3% | +3.2 |
| FY2019 | Dec 31, 2019 | 69.1% | −2.2 |
| FY2018 | Dec 31, 2018 | 71.3% | +0.7 |
| FY2017 | Dec 31, 2017 | 70.7% | −3.9 |
| FY2016 | Dec 31, 2016 | 74.5% | −1.9 |
| FY2015 | Dec 31, 2015 | 76.4% | +1.2 |
| FY2014 | Dec 31, 2014 | 75.2% | +3.4 |
| FY2013 | Dec 31, 2013 | 71.8% | −2.0 |
| FY2012 | Dec 31, 2012 | 73.8% | +0.2 |
| FY2011 | Dec 31, 2011 | 73.6% | +0.7 |
| FY2010 | Dec 31, 2010 | 72.9% | +0.2 |
| FY2009 | Dec 31, 2009 | 72.7% | +2.7 |
| FY2008 | Dec 31, 2008 | 70.0% | +1.5 |
| FY2007 | Dec 31, 2007 | 68.5% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 68.3% | −3.6 |
| Q2 FY2026 | Jun 30, 2026 | 71.3% | −1.2 |
| Q1 FY2026 | Mar 31, 2026 | 70.2% | −2.7 |
| Q4 FY2025 | Dec 31, 2025 | 67.2% | +6.2 |
| Q3 FY2025 | Sep 30, 2025 | 71.9% | −3.2 |
| Q2 FY2025 | Jun 30, 2025 | 72.5% | −0.7 |
| Q1 FY2025 | Mar 31, 2025 | 72.9% | −2.4 |
| Q4 FY2024 | Dec 31, 2024 | 61.0% | −15.1 |
| Q3 FY2024 | Sep 30, 2024 | 75.1% | −2.0 |
| Q2 FY2024 | Jun 30, 2024 | 73.2% | −1.2 |
| Q1 FY2024 | Mar 31, 2024 | 75.3% | −2.1 |
| Q4 FY2023 | Dec 31, 2023 | 76.1% | −1.2 |
| Q3 FY2023 | Sep 30, 2023 | 77.1% | −1.9 |
| Q2 FY2023 | Jun 30, 2023 | 74.4% | −2.7 |
| Q1 FY2023 | Mar 31, 2023 | 77.4% | −1.4 |
| Q4 FY2022 | Dec 31, 2022 | 77.3% | −3.1 |
| Q3 FY2022 | Sep 30, 2022 | 79.0% | −1.3 |
| Q2 FY2022 | Jun 30, 2022 | 77.1% | −1.9 |
| Q1 FY2022 | Mar 31, 2022 | 78.8% | +4.4 |
| Q4 FY2021 | Dec 31, 2021 | 80.3% | +6.6 |
| Q3 FY2021 | Sep 30, 2021 | 80.3% | +4.0 |
| Q2 FY2021 | Jun 30, 2021 | 79.0% | +5.7 |
| Q1 FY2021 | Mar 31, 2021 | 74.3% | +8.3 |
| Q4 FY2020 | Dec 31, 2020 | 73.7% | +5.1 |
| Q3 FY2020 | Sep 30, 2020 | 76.3% | +6.1 |
| Q2 FY2020 | Jun 30, 2020 | 73.4% | +4.8 |
| Q1 FY2020 | Mar 31, 2020 | 66.0% | −3.2 |
| Q4 FY2019 | Dec 31, 2019 | 68.6% | −3.4 |
| Q3 FY2019 | Sep 30, 2019 | 70.2% | −1.2 |
| Q2 FY2019 | Jun 30, 2019 | 68.6% | −3.3 |
| Q1 FY2019 | Mar 31, 2019 | 69.2% | −0.7 |
| Q4 FY2018 | Dec 31, 2018 | 72.0% | +2.9 |
| Q3 FY2018 | Sep 30, 2018 | 71.4% | +1.4 |
| Q2 FY2018 | Jun 30, 2018 | 71.9% | +2.4 |
| Q1 FY2018 | Mar 31, 2018 | 69.9% | −4.5 |
| Q4 FY2017 | Dec 31, 2017 | 69.2% | −4.5 |
| Q3 FY2017 | Sep 30, 2017 | 69.9% | – |
| Q2 FY2017 | Jun 30, 2017 | 69.5% | – |
| Q1 FY2017 | Mar 31, 2017 | 74.3% | – |
| Q4 FY2016 | Dec 31, 2016 | 73.6% | – |
See a number that looks wrong?